There were 1,662 press releases posted in the last 24 hours and 442,844 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Nabriva Therapeutics Receives FDA Acknowledgement of New Drug Application Resubmission for Intravenous CONTEPO™ (fosfomycin) for Injection

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image